Precision nanomedicines for prostate cancer

Anna Cifuentes-Rius, Lisa M. Butler, Nicolas H. Voelcker

Research output: Contribution to journalEditorialOtherpeer-review

7 Citations (Scopus)


Over the past decade, advances in nanotechnology have enabled the production of nanomaterial-based therapeutics. These nanomaterials, with a submicrometer size and high surface area, when used to diagnose and treat disease are known as nanomedicines. Nanomedicine is an interdisciplinary field combining nanotechnology and pharmaceutical and biomedical science, which offers new possibilities for the design of targeted-delivery platforms for both diagnosis and therapy. In cancer research, this technology has the potential to revolutionize the way we manage the malignancy not only by how treatment is directed but also from a diagnosis and prognosis perspective. Such nanomedicines will allow focus on early detection of disease, combining therapies by loading multiple therapeutics into nanoscale-delivery systems, and improved tumor specificity by selective targeting and delivery.
Original languageEnglish
Pages (from-to)803-807
Number of pages5
Issue number8
Publication statusPublished - 1 Apr 2018


  • Biomarkers
  • Nanomedicine
  • Nanotechnology
  • Precision medicine
  • Prostate cancer

Cite this